Advertisement
UK markets close in 3 hours 10 minutes
  • FTSE 100

    8,098.67
    +58.29 (+0.72%)
     
  • FTSE 250

    19,731.47
    +12.10 (+0.06%)
     
  • AIM

    755.54
    +0.85 (+0.11%)
     
  • GBP/EUR

    1.1667
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2503
    +0.0041 (+0.33%)
     
  • Bitcoin GBP

    51,176.46
    -2,144.64 (-4.02%)
     
  • CMC Crypto 200

    1,355.66
    -26.91 (-1.95%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    83.15
    +0.34 (+0.41%)
     
  • GOLD FUTURES

    2,340.30
    +1.90 (+0.08%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,998.28
    -90.42 (-0.50%)
     
  • CAC 40

    8,024.12
    -67.74 (-0.84%)
     

Why Teligent Rose ~10.4% Yesterday

Why Teligent Rose ~10.4% Yesterday

On June 14, Teligent (TLGT) stock rose ~10.4% on the news of the FDA approval of its diflorasone diacetate ointment 0.05%. Investors were pleased with the news, and TLGT stock soared more than 10%. Teligent plans to launch the product in the third quarter of 2018.